//
A. Seragnoli
Monica Bellei
Young-Hyeh Ko
Massimo Federico
Julie M Vose
Joseph M. Connors
Francine M. Foss
Steven M. Horwitz
Silvia Montoto
Aaron Polliack
Pier Luigi Zinzani
Emanuele Zucca
Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
Department of Hematology, Hadassah University Hospital and Hebrew University Medical School, Jeruslaem, Israel
Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom
Department of Hematology and Oncology, Policlinico S.Orsola-Malpighi, Bologna, Italy
Department of Diagnostic, Clinical and Public Health Medicine, University of Modena and Reggio Emilia, Modena, Italy
Haematopathology, Department L. & A. Seragnoli, University of Bologna, Bologna, Italy
British Columbia Cancer Agency, Vancouver, BC, Canada
Canada
Italy
United Kingdom
Switzerland
Israel
N/A
Oncology (ONC)
Peripheral T-cell lymphoma
Serine Peptidase Inhibitor, Kazal Type 1
N/A
N/A
N/A
NA
N/A
N/A
Interim